| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Preoptic Area | 35 | 2022 | 132 | 6.700 |
Why?
|
| Hypothalamus | 53 | 2018 | 999 | 5.180 |
Why?
|
| Periodicals as Topic | 22 | 2019 | 1463 | 3.690 |
Why?
|
| Sleep | 52 | 2022 | 4765 | 3.390 |
Why?
|
| Body Temperature Regulation | 13 | 2021 | 292 | 3.210 |
Why?
|
| Neurons | 103 | 2024 | 9458 | 3.200 |
Why?
|
| Wakefulness | 29 | 2024 | 1265 | 3.070 |
Why?
|
| Neurosciences | 16 | 2012 | 366 | 3.050 |
Why?
|
| Neurology | 11 | 2022 | 778 | 2.960 |
Why?
|
| Circadian Rhythm | 29 | 2024 | 2574 | 2.810 |
Why?
|
| Hypercapnia | 5 | 2024 | 261 | 2.470 |
Why?
|
| Peer Review, Research | 9 | 2014 | 340 | 2.430 |
Why?
|
| Suprachiasmatic Nucleus | 13 | 2024 | 140 | 2.310 |
Why?
|
| Fever | 18 | 2020 | 1618 | 2.080 |
Why?
|
| Neural Pathways | 63 | 2020 | 3057 | 2.060 |
Why?
|
| Publishing | 14 | 2019 | 833 | 1.980 |
Why?
|
| Glutamic Acid | 13 | 2022 | 1176 | 1.930 |
Why?
|
| Arousal | 14 | 2022 | 1166 | 1.830 |
Why?
|
| Sleep, REM | 15 | 2024 | 594 | 1.680 |
Why?
|
| Hydrocephalus, Normal Pressure | 3 | 2017 | 100 | 1.590 |
Why?
|
| Pons | 29 | 2013 | 240 | 1.420 |
Why?
|
| Brain Stem | 21 | 2024 | 858 | 1.420 |
Why?
|
| Receptors, Prostaglandin E, EP3 Subtype | 6 | 2020 | 22 | 1.390 |
Why?
|
| Rats | 141 | 2019 | 23729 | 1.390 |
Why?
|
| Afferent Pathways | 18 | 2012 | 298 | 1.340 |
Why?
|
| Neuropeptides | 21 | 2013 | 944 | 1.340 |
Why?
|
| Lipopolysaccharides | 17 | 2020 | 2206 | 1.240 |
Why?
|
| Body Temperature | 13 | 2021 | 782 | 1.220 |
Why?
|
| Hypothalamic Area, Lateral | 14 | 2019 | 108 | 1.160 |
Why?
|
| Autonomic Nervous System | 10 | 2016 | 701 | 1.150 |
Why?
|
| Animals | 245 | 2024 | 168388 | 1.110 |
Why?
|
| Neuroanatomy | 4 | 2016 | 70 | 1.100 |
Why?
|
| Sleep Deprivation | 6 | 2019 | 843 | 1.070 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 8 | 2018 | 46 | 1.070 |
Why?
|
| Rats, Sprague-Dawley | 65 | 2019 | 8166 | 1.060 |
Why?
|
| Proto-Oncogene Proteins c-fos | 26 | 2015 | 586 | 1.010 |
Why?
|
| Receptors, Prostaglandin E | 5 | 2008 | 56 | 0.980 |
Why?
|
| Editorial Policies | 4 | 2015 | 458 | 0.980 |
Why?
|
| Galanin | 9 | 2021 | 42 | 0.980 |
Why?
|
| Medulla Oblongata | 22 | 2016 | 248 | 0.970 |
Why?
|
| Dorsomedial Hypothalamic Nucleus | 7 | 2008 | 14 | 0.960 |
Why?
|
| Carbon Dioxide | 4 | 2024 | 1146 | 0.930 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 14 | 2018 | 114 | 0.910 |
Why?
|
| Melanins | 9 | 2016 | 289 | 0.900 |
Why?
|
| Spinal Cord | 28 | 2016 | 1817 | 0.890 |
Why?
|
| gamma-Aminobutyric Acid | 12 | 2024 | 1140 | 0.880 |
Why?
|
| Synaptic Transmission | 13 | 2024 | 1172 | 0.860 |
Why?
|
| Smoke | 2 | 2015 | 234 | 0.850 |
Why?
|
| Hypothalamic Hormones | 5 | 2016 | 145 | 0.820 |
Why?
|
| Pituitary Hormones | 5 | 2016 | 182 | 0.820 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 15 | 2013 | 2870 | 0.820 |
Why?
|
| Industry | 2 | 2015 | 364 | 0.810 |
Why?
|
| Dinoprostone | 7 | 2016 | 597 | 0.810 |
Why?
|
| Perceptual Disorders | 1 | 2024 | 198 | 0.810 |
Why?
|
| Immunohistochemistry | 46 | 2015 | 11070 | 0.800 |
Why?
|
| Cell Count | 25 | 2015 | 1835 | 0.790 |
Why?
|
| Aggression | 3 | 2018 | 750 | 0.770 |
Why?
|
| Calcitonin Gene-Related Peptide | 8 | 2024 | 323 | 0.770 |
Why?
|
| Efferent Pathways | 20 | 2016 | 165 | 0.760 |
Why?
|
| Nerve Net | 11 | 2018 | 2288 | 0.760 |
Why?
|
| Central Nervous System | 10 | 2017 | 1337 | 0.760 |
Why?
|
| Brain | 53 | 2022 | 27103 | 0.760 |
Why?
|
| Vasoactive Intestinal Peptide | 3 | 2018 | 180 | 0.750 |
Why?
|
| Narcolepsy | 7 | 2013 | 199 | 0.730 |
Why?
|
| Heating | 1 | 2021 | 104 | 0.720 |
Why?
|
| REM Sleep Behavior Disorder | 5 | 2013 | 108 | 0.710 |
Why?
|
| Biomedical Research | 5 | 2024 | 3429 | 0.710 |
Why?
|
| Alzheimer Disease | 14 | 2021 | 8592 | 0.700 |
Why?
|
| Hypothalamic Diseases | 3 | 2021 | 134 | 0.690 |
Why?
|
| Research Personnel | 2 | 2015 | 588 | 0.670 |
Why?
|
| Parvalbumins | 6 | 2013 | 261 | 0.660 |
Why?
|
| Bankruptcy | 1 | 2019 | 26 | 0.640 |
Why?
|
| Antibodies | 7 | 2024 | 2421 | 0.630 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 7 | 2004 | 318 | 0.630 |
Why?
|
| Cholinergic Fibers | 9 | 2006 | 69 | 0.620 |
Why?
|
| Prostaglandins | 5 | 2012 | 398 | 0.620 |
Why?
|
| Hippocampus | 14 | 2019 | 3763 | 0.600 |
Why?
|
| Appetite Regulation | 2 | 2016 | 84 | 0.590 |
Why?
|
| Dendritic Spines | 1 | 2019 | 243 | 0.590 |
Why?
|
| Cerebral Cortex | 28 | 2016 | 5776 | 0.570 |
Why?
|
| Actigraphy | 5 | 2015 | 520 | 0.570 |
Why?
|
| Motor Activity | 9 | 2020 | 2710 | 0.570 |
Why?
|
| Locus Coeruleus | 9 | 2024 | 230 | 0.560 |
Why?
|
| Drinking Behavior | 1 | 2017 | 103 | 0.560 |
Why?
|
| Forkhead Transcription Factors | 1 | 2024 | 1612 | 0.550 |
Why?
|
| Biological Clocks | 3 | 2008 | 318 | 0.550 |
Why?
|
| Epilepsies, Partial | 3 | 2014 | 431 | 0.540 |
Why?
|
| Mice | 51 | 2024 | 81474 | 0.540 |
Why?
|
| Writing | 2 | 2016 | 199 | 0.540 |
Why?
|
| Thirst | 1 | 2016 | 42 | 0.540 |
Why?
|
| Solitary Nucleus | 3 | 2016 | 54 | 0.540 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 2 | 2014 | 44 | 0.530 |
Why?
|
| Journal Impact Factor | 2 | 2014 | 153 | 0.530 |
Why?
|
| Norepinephrine | 5 | 2012 | 897 | 0.530 |
Why?
|
| Atrial Natriuretic Factor | 10 | 1995 | 350 | 0.530 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2019 | 385 | 0.520 |
Why?
|
| Nerve Tissue Proteins | 22 | 2005 | 4414 | 0.520 |
Why?
|
| Rod Opsins | 3 | 2014 | 108 | 0.520 |
Why?
|
| Medicare | 3 | 2019 | 6758 | 0.520 |
Why?
|
| Prostaglandin D2 | 2 | 2014 | 108 | 0.510 |
Why?
|
| School Admission Criteria | 1 | 2016 | 107 | 0.510 |
Why?
|
| Visceral Afferents | 3 | 2015 | 9 | 0.510 |
Why?
|
| Feedback, Physiological | 2 | 2016 | 476 | 0.510 |
Why?
|
| Periaqueductal Gray | 4 | 2013 | 110 | 0.510 |
Why?
|
| Health Care Reform | 2 | 2015 | 1246 | 0.500 |
Why?
|
| Neurologic Examination | 1 | 2018 | 916 | 0.500 |
Why?
|
| Drinking | 1 | 2016 | 199 | 0.500 |
Why?
|
| Disclosure | 2 | 2014 | 748 | 0.490 |
Why?
|
| Humans | 165 | 2024 | 761326 | 0.490 |
Why?
|
| Cholera Toxin | 14 | 2015 | 559 | 0.480 |
Why?
|
| Choline O-Acetyltransferase | 15 | 2012 | 155 | 0.480 |
Why?
|
| Names | 1 | 2015 | 54 | 0.480 |
Why?
|
| Histamine | 5 | 2019 | 497 | 0.480 |
Why?
|
| Data Interpretation, Statistical | 4 | 2020 | 2691 | 0.480 |
Why?
|
| Male | 167 | 2024 | 360621 | 0.480 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2016 | 195 | 0.470 |
Why?
|
| Mice, Transgenic | 12 | 2020 | 9534 | 0.470 |
Why?
|
| Food | 3 | 2008 | 772 | 0.470 |
Why?
|
| Nervous System Diseases | 3 | 2015 | 1665 | 0.470 |
Why?
|
| Sleep Stages | 6 | 2019 | 693 | 0.460 |
Why?
|
| Green Fluorescent Proteins | 11 | 2015 | 2062 | 0.460 |
Why?
|
| Hypothalamus, Posterior | 3 | 2017 | 12 | 0.450 |
Why?
|
| Rats, Inbred Strains | 35 | 1992 | 2090 | 0.450 |
Why?
|
| Thermogenesis | 1 | 2018 | 475 | 0.450 |
Why?
|
| Biotin | 6 | 2015 | 254 | 0.450 |
Why?
|
| Presynaptic Terminals | 5 | 2013 | 302 | 0.450 |
Why?
|
| Brain Mapping | 35 | 2018 | 6626 | 0.450 |
Why?
|
| Hydrocephalus | 1 | 2020 | 764 | 0.450 |
Why?
|
| Neurotransmitter Agents | 5 | 2014 | 665 | 0.450 |
Why?
|
| Deception | 1 | 2014 | 98 | 0.440 |
Why?
|
| Acetylcholinesterase | 6 | 2004 | 156 | 0.430 |
Why?
|
| Dopamine | 6 | 2009 | 1605 | 0.430 |
Why?
|
| Economic Recession | 1 | 2014 | 79 | 0.430 |
Why?
|
| Energy Metabolism | 5 | 2014 | 2879 | 0.420 |
Why?
|
| Financing, Organized | 1 | 2014 | 204 | 0.420 |
Why?
|
| Deductibles and Coinsurance | 1 | 2015 | 316 | 0.420 |
Why?
|
| Stilbamidines | 4 | 2003 | 43 | 0.420 |
Why?
|
| Respiration | 6 | 2024 | 1657 | 0.420 |
Why?
|
| Corpus Striatum | 7 | 2010 | 1235 | 0.410 |
Why?
|
| Light | 6 | 2014 | 1351 | 0.400 |
Why?
|
| Raphe Nuclei | 4 | 2009 | 103 | 0.400 |
Why?
|
| Electromyography | 12 | 2018 | 1393 | 0.400 |
Why?
|
| Axonal Transport | 11 | 2002 | 178 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 23 | 2024 | 22154 | 0.390 |
Why?
|
| Neurobiology | 1 | 2013 | 137 | 0.390 |
Why?
|
| Peer Review | 1 | 2014 | 217 | 0.390 |
Why?
|
| Authorship | 1 | 2015 | 284 | 0.390 |
Why?
|
| Brain Chemistry | 10 | 2003 | 959 | 0.390 |
Why?
|
| Sympathetic Nervous System | 5 | 2006 | 518 | 0.390 |
Why?
|
| Inflammation | 8 | 2020 | 10760 | 0.380 |
Why?
|
| Societies, Medical | 3 | 2019 | 3905 | 0.380 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 5 | 2020 | 53 | 0.380 |
Why?
|
| Work Schedule Tolerance | 1 | 2015 | 551 | 0.370 |
Why?
|
| Circadian Clocks | 1 | 2013 | 163 | 0.370 |
Why?
|
| Serotonin | 2 | 2020 | 1041 | 0.370 |
Why?
|
| Retinal Ganglion Cells | 4 | 2014 | 811 | 0.360 |
Why?
|
| Optic Nerve | 1 | 2014 | 572 | 0.350 |
Why?
|
| Optic Nerve Diseases | 1 | 2014 | 342 | 0.350 |
Why?
|
| Eating | 6 | 2007 | 1537 | 0.340 |
Why?
|
| Parkinson Disease | 10 | 2019 | 2876 | 0.340 |
Why?
|
| Women | 1 | 2011 | 223 | 0.340 |
Why?
|
| Catecholamines | 8 | 2009 | 386 | 0.330 |
Why?
|
| Immune System | 2 | 2010 | 794 | 0.330 |
Why?
|
| Sexual Behavior | 2 | 2021 | 2179 | 0.330 |
Why?
|
| Neuroendocrinology | 1 | 2009 | 5 | 0.330 |
Why?
|
| Conflict of Interest | 1 | 2014 | 554 | 0.330 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2009 | 65 | 0.330 |
Why?
|
| Sensation | 3 | 2002 | 337 | 0.330 |
Why?
|
| Electroencephalography | 19 | 2019 | 6224 | 0.330 |
Why?
|
| Lewy Body Disease | 2 | 2015 | 252 | 0.320 |
Why?
|
| Receptors, Neuropeptide | 3 | 2007 | 106 | 0.320 |
Why?
|
| Prosencephalon | 5 | 2017 | 305 | 0.320 |
Why?
|
| Ibotenic Acid | 6 | 2011 | 59 | 0.310 |
Why?
|
| In Situ Hybridization | 15 | 2010 | 1900 | 0.310 |
Why?
|
| Tegmentum Mesencephali | 10 | 2006 | 59 | 0.310 |
Why?
|
| Staining and Labeling | 6 | 2010 | 1085 | 0.310 |
Why?
|
| Anesthesia | 3 | 2008 | 1592 | 0.310 |
Why?
|
| RNA, Messenger | 24 | 2006 | 12787 | 0.310 |
Why?
|
| Multiple System Atrophy | 3 | 2015 | 129 | 0.300 |
Why?
|
| Interinstitutional Relations | 1 | 2009 | 236 | 0.300 |
Why?
|
| Basal Ganglia | 7 | 2005 | 554 | 0.300 |
Why?
|
| Nerve Degeneration | 8 | 2010 | 748 | 0.300 |
Why?
|
| Feeding Behavior | 9 | 2013 | 3187 | 0.300 |
Why?
|
| Nerve Regeneration | 1 | 2013 | 795 | 0.300 |
Why?
|
| Leptin | 12 | 2012 | 1595 | 0.300 |
Why?
|
| Viscera | 5 | 2000 | 138 | 0.290 |
Why?
|
| Dextrans | 6 | 2015 | 573 | 0.290 |
Why?
|
| Rest | 4 | 2018 | 919 | 0.290 |
Why?
|
| Diencephalon | 4 | 2001 | 54 | 0.290 |
Why?
|
| Motor Neurons | 5 | 2015 | 869 | 0.290 |
Why?
|
| Printing | 1 | 2007 | 46 | 0.290 |
Why?
|
| Microinjections | 9 | 2012 | 321 | 0.280 |
Why?
|
| Cyclooxygenase Inhibitors | 3 | 2014 | 361 | 0.280 |
Why?
|
| Drug Costs | 1 | 2015 | 1183 | 0.280 |
Why?
|
| Models, Neurological | 7 | 2009 | 1767 | 0.280 |
Why?
|
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 8 | 2013 | 35 | 0.280 |
Why?
|
| Dependovirus | 6 | 2012 | 715 | 0.280 |
Why?
|
| Carrier Proteins | 7 | 2003 | 4936 | 0.280 |
Why?
|
| Excitatory Postsynaptic Potentials | 6 | 2018 | 369 | 0.270 |
Why?
|
| Light Signal Transduction | 2 | 2003 | 31 | 0.270 |
Why?
|
| History, 20th Century | 4 | 2016 | 2770 | 0.270 |
Why?
|
| Neuroanatomical Tract-Tracing Techniques | 2 | 2016 | 40 | 0.260 |
Why?
|
| Color | 1 | 2007 | 299 | 0.260 |
Why?
|
| Benzhydryl Compounds | 3 | 2004 | 916 | 0.260 |
Why?
|
| Trigeminal Nucleus, Spinal | 3 | 1995 | 21 | 0.260 |
Why?
|
| Antigens | 6 | 2008 | 1446 | 0.260 |
Why?
|
| Internship and Residency | 2 | 2016 | 5877 | 0.250 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2015 | 1186 | 0.250 |
Why?
|
| Hamartoma | 2 | 2021 | 235 | 0.250 |
Why?
|
| Hypothalamus, Anterior | 3 | 2001 | 12 | 0.250 |
Why?
|
| Pedunculopontine Tegmental Nucleus | 2 | 2019 | 17 | 0.250 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 1792 | 0.250 |
Why?
|
| alpha-Synuclein | 2 | 2015 | 750 | 0.240 |
Why?
|
| Signal Transduction | 8 | 2024 | 23427 | 0.240 |
Why?
|
| Adenosine | 4 | 2006 | 805 | 0.240 |
Why?
|
| Motivation | 2 | 2023 | 2006 | 0.240 |
Why?
|
| Phytohemagglutinins | 7 | 2012 | 168 | 0.230 |
Why?
|
| Neurofibrillary Tangles | 4 | 1996 | 457 | 0.230 |
Why?
|
| Cerebral Arteries | 3 | 1991 | 490 | 0.230 |
Why?
|
| Homeostasis | 8 | 2015 | 3322 | 0.230 |
Why?
|
| Interneurons | 4 | 2010 | 593 | 0.230 |
Why?
|
| Gene Expression | 8 | 2016 | 7582 | 0.230 |
Why?
|
| Cyclooxygenase 2 | 5 | 2010 | 597 | 0.230 |
Why?
|
| Blood Pressure | 8 | 2015 | 8485 | 0.230 |
Why?
|
| Synapses | 4 | 2009 | 1769 | 0.230 |
Why?
|
| Art | 1 | 2024 | 64 | 0.220 |
Why?
|
| Neural Inhibition | 8 | 2013 | 590 | 0.220 |
Why?
|
| Emotions | 3 | 2005 | 2738 | 0.220 |
Why?
|
| Ascomycota | 1 | 2024 | 81 | 0.220 |
Why?
|
| Vesicular Inhibitory Amino Acid Transport Proteins | 3 | 2019 | 43 | 0.220 |
Why?
|
| Students, Medical | 1 | 2016 | 1930 | 0.220 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2018 | 1081 | 0.210 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2007 | 1249 | 0.210 |
Why?
|
| Nerve Fibers | 7 | 1999 | 708 | 0.210 |
Why?
|
| Paintings | 1 | 2024 | 103 | 0.210 |
Why?
|
| Cerebellum | 5 | 2022 | 1500 | 0.210 |
Why?
|
| Genetic Vectors | 5 | 2013 | 3393 | 0.210 |
Why?
|
| Mice, Knockout | 13 | 2020 | 14409 | 0.210 |
Why?
|
| Neuroprotective Agents | 2 | 2013 | 957 | 0.210 |
Why?
|
| Cold Temperature | 2 | 2021 | 786 | 0.210 |
Why?
|
| Substantia Innominata | 4 | 2006 | 23 | 0.210 |
Why?
|
| Health Expenditures | 1 | 2015 | 2365 | 0.210 |
Why?
|
| Philosophy | 1 | 2002 | 68 | 0.200 |
Why?
|
| Proteins | 7 | 1999 | 6034 | 0.200 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2273 | 0.200 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2373 | 0.200 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 1135 | 0.200 |
Why?
|
| Health Care Costs | 1 | 2015 | 3243 | 0.200 |
Why?
|
| Putamen | 4 | 2010 | 292 | 0.200 |
Why?
|
| Isoenzymes | 3 | 2004 | 1688 | 0.200 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2003 | 203 | 0.190 |
Why?
|
| Activity Cycles | 1 | 2001 | 47 | 0.190 |
Why?
|
| Functional Laterality | 4 | 2013 | 2256 | 0.190 |
Why?
|
| Amygdala | 8 | 2000 | 1353 | 0.190 |
Why?
|
| Globus Pallidus | 4 | 2020 | 250 | 0.190 |
Why?
|
| History, 21st Century | 3 | 2014 | 1567 | 0.190 |
Why?
|
| Acetylcholine | 4 | 2013 | 628 | 0.190 |
Why?
|
| Time Factors | 13 | 2018 | 39974 | 0.190 |
Why?
|
| Analgesics | 1 | 2008 | 1070 | 0.190 |
Why?
|
| Substance-Related Disorders | 2 | 2009 | 4419 | 0.190 |
Why?
|
| Neuronal Plasticity | 1 | 2009 | 1435 | 0.190 |
Why?
|
| Acoustic Stimulation | 2 | 2017 | 1235 | 0.180 |
Why?
|
| Transduction, Genetic | 2 | 2015 | 901 | 0.180 |
Why?
|
| Stress, Psychological | 3 | 2020 | 4477 | 0.180 |
Why?
|
| Sheep | 5 | 1996 | 1440 | 0.180 |
Why?
|
| Reticular Formation | 9 | 2006 | 59 | 0.180 |
Why?
|
| Specific Pathogen-Free Organisms | 7 | 2019 | 221 | 0.180 |
Why?
|
| Luminescent Proteins | 4 | 2013 | 836 | 0.180 |
Why?
|
| Limbic System | 7 | 1996 | 419 | 0.180 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 3768 | 0.180 |
Why?
|
| Cognition | 4 | 2015 | 6987 | 0.170 |
Why?
|
| Caudate Nucleus | 4 | 2010 | 389 | 0.170 |
Why?
|
| Period Circadian Proteins | 2 | 2012 | 96 | 0.170 |
Why?
|
| Mesencephalon | 9 | 2009 | 332 | 0.170 |
Why?
|
| Horseradish Peroxidase | 13 | 1991 | 166 | 0.170 |
Why?
|
| Trigeminal Nuclei | 2 | 2001 | 39 | 0.170 |
Why?
|
| Female | 47 | 2021 | 392485 | 0.170 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2017 | 975 | 0.170 |
Why?
|
| Psychophysiology | 1 | 2000 | 136 | 0.170 |
Why?
|
| Vagus Nerve | 4 | 2014 | 458 | 0.170 |
Why?
|
| Body Weight | 5 | 2012 | 4614 | 0.170 |
Why?
|
| Histocytochemistry | 10 | 1999 | 698 | 0.170 |
Why?
|
| Cardiovascular System | 5 | 1992 | 835 | 0.170 |
Why?
|
| Brain Diseases | 3 | 2016 | 1545 | 0.170 |
Why?
|
| Receptor, Adenosine A1 | 3 | 2009 | 42 | 0.160 |
Why?
|
| Cats | 7 | 2011 | 975 | 0.160 |
Why?
|
| Electric Stimulation | 6 | 2011 | 1735 | 0.160 |
Why?
|
| Ethics, Professional | 1 | 1999 | 100 | 0.160 |
Why?
|
| Memory | 3 | 2005 | 2187 | 0.160 |
Why?
|
| Polyradiculoneuropathy | 1 | 1999 | 65 | 0.160 |
Why?
|
| Antibody Specificity | 4 | 2008 | 1060 | 0.160 |
Why?
|
| Respiratory Center | 2 | 2014 | 18 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3612 | 0.160 |
Why?
|
| Longevity | 1 | 2006 | 1065 | 0.160 |
Why?
|
| Cholecystokinin | 4 | 2006 | 117 | 0.160 |
Why?
|
| Tuberculosis, Meningeal | 1 | 1999 | 47 | 0.160 |
Why?
|
| Aging | 5 | 2014 | 8704 | 0.160 |
Why?
|
| Cerebral Ventricles | 5 | 2003 | 542 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7389 | 0.150 |
Why?
|
| Tolmetin | 1 | 1998 | 24 | 0.150 |
Why?
|
| Motor Neuron Disease | 1 | 1999 | 97 | 0.150 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2020 | 324 | 0.150 |
Why?
|
| Acute-Phase Reaction | 2 | 1996 | 91 | 0.150 |
Why?
|
| Reflex, Abnormal | 1 | 1998 | 83 | 0.150 |
Why?
|
| Rats, Wistar | 6 | 2013 | 1846 | 0.150 |
Why?
|
| Injections, Intravenous | 5 | 1998 | 1379 | 0.150 |
Why?
|
| Eye Movements | 2 | 2013 | 511 | 0.150 |
Why?
|
| State Medicine | 1 | 2019 | 216 | 0.150 |
Why?
|
| Receptors, Opioid, mu | 1 | 1999 | 167 | 0.150 |
Why?
|
| Cognition Disorders | 1 | 2012 | 3979 | 0.150 |
Why?
|
| Thalamus | 7 | 2011 | 1044 | 0.150 |
Why?
|
| Patch-Clamp Techniques | 3 | 2017 | 927 | 0.150 |
Why?
|
| Primates | 2 | 2000 | 524 | 0.150 |
Why?
|
| Behavior, Animal | 4 | 2016 | 1878 | 0.150 |
Why?
|
| Research | 1 | 2006 | 1977 | 0.150 |
Why?
|
| Computer Graphics | 1 | 1999 | 340 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2006 | 2246 | 0.150 |
Why?
|
| Glutamate Decarboxylase | 5 | 2019 | 239 | 0.150 |
Why?
|
| tau Proteins | 4 | 1996 | 2095 | 0.140 |
Why?
|
| Receptors, GABA-A | 3 | 2008 | 623 | 0.140 |
Why?
|
| Receptors, Cell Surface | 3 | 2009 | 2820 | 0.140 |
Why?
|
| Fluorescent Dyes | 10 | 2003 | 1901 | 0.140 |
Why?
|
| Corticosterone | 1 | 2018 | 305 | 0.140 |
Why?
|
| Pain | 5 | 2009 | 5077 | 0.140 |
Why?
|
| Haplorhini | 5 | 1993 | 529 | 0.140 |
Why?
|
| Meningeal Arteries | 1 | 1997 | 68 | 0.140 |
Why?
|
| Physicians | 1 | 2015 | 4591 | 0.140 |
Why?
|
| Dementia | 1 | 2011 | 2686 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2010 | 3543 | 0.140 |
Why?
|
| Repressor Proteins | 4 | 2024 | 2985 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 10 | 1999 | 2468 | 0.140 |
Why?
|
| Neurofibrils | 4 | 1994 | 75 | 0.140 |
Why?
|
| Okadaic Acid | 1 | 1996 | 67 | 0.140 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2009 | 1871 | 0.140 |
Why?
|
| Microscopy, Electron | 6 | 2012 | 2560 | 0.130 |
Why?
|
| Photography | 1 | 1999 | 532 | 0.130 |
Why?
|
| Fatigue | 1 | 2023 | 1551 | 0.130 |
Why?
|
| Sex Characteristics | 2 | 2021 | 2637 | 0.130 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1996 | 260 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2014 | 5334 | 0.130 |
Why?
|
| Wheat Germ Agglutinins | 9 | 1991 | 47 | 0.130 |
Why?
|
| Stress, Physiological | 2 | 2018 | 1403 | 0.130 |
Why?
|
| Bibliometrics | 1 | 1999 | 352 | 0.130 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 9414 | 0.130 |
Why?
|
| Cardiovascular Physiological Phenomena | 3 | 1992 | 241 | 0.130 |
Why?
|
| Cerebellar Nuclei | 1 | 1995 | 51 | 0.130 |
Why?
|
| Reward | 1 | 2002 | 971 | 0.130 |
Why?
|
| Transgenes | 2 | 1998 | 1009 | 0.130 |
Why?
|
| Hypertension | 1 | 2015 | 8539 | 0.130 |
Why?
|
| Motor Cortex | 3 | 1996 | 1006 | 0.130 |
Why?
|
| Parasympathetic Nervous System | 2 | 1994 | 141 | 0.120 |
Why?
|
| Thalamic Nuclei | 5 | 1989 | 111 | 0.120 |
Why?
|
| Reference Standards | 2 | 2015 | 1004 | 0.120 |
Why?
|
| Interleukin-1 | 2 | 2010 | 1250 | 0.120 |
Why?
|
| Stroke | 3 | 2015 | 9749 | 0.120 |
Why?
|
| Thiazines | 1 | 2014 | 38 | 0.120 |
Why?
|
| Darkness | 4 | 2003 | 158 | 0.120 |
Why?
|
| Myocardium | 3 | 2006 | 4723 | 0.120 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2017 | 240 | 0.120 |
Why?
|
| United States | 7 | 2019 | 72317 | 0.120 |
Why?
|
| Tourette Syndrome | 2 | 2010 | 395 | 0.120 |
Why?
|
| Hypotension, Orthostatic | 1 | 1998 | 258 | 0.120 |
Why?
|
| Hypothermia | 1 | 1996 | 188 | 0.120 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 1998 | 370 | 0.120 |
Why?
|
| Ventriculostomy | 1 | 2016 | 131 | 0.120 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 1990 | 361 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2006 | 1964 | 0.110 |
Why?
|
| Retina | 2 | 2010 | 2656 | 0.110 |
Why?
|
| Ventral Thalamic Nuclei | 2 | 2005 | 43 | 0.110 |
Why?
|
| Neurites | 1 | 1996 | 391 | 0.110 |
Why?
|
| Congresses as Topic | 1 | 2019 | 803 | 0.110 |
Why?
|
| Receptors, AMPA | 1 | 1995 | 336 | 0.110 |
Why?
|
| Prefrontal Cortex | 4 | 2013 | 2219 | 0.110 |
Why?
|
| Gene Transfer Techniques | 2 | 2009 | 1205 | 0.110 |
Why?
|
| Aged, 80 and over | 10 | 2015 | 58946 | 0.110 |
Why?
|
| Muscarinic Agonists | 1 | 2013 | 91 | 0.110 |
Why?
|
| Anesthetics | 4 | 2007 | 523 | 0.110 |
Why?
|
| Carbachol | 1 | 2013 | 223 | 0.110 |
Why?
|
| Nitric Oxide Synthase | 1 | 1996 | 906 | 0.110 |
Why?
|
| Insulin | 2 | 2022 | 6595 | 0.110 |
Why?
|
| Silver Staining | 3 | 2002 | 62 | 0.110 |
Why?
|
| Thiazoles | 4 | 2014 | 1516 | 0.110 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 18234 | 0.110 |
Why?
|
| Plethysmography | 1 | 2013 | 175 | 0.110 |
Why?
|
| Adrenergic Fibers | 2 | 1992 | 21 | 0.110 |
Why?
|
| Cataplexy | 1 | 2013 | 61 | 0.100 |
Why?
|
| Sensation Disorders | 1 | 2014 | 160 | 0.100 |
Why?
|
| Coma | 1 | 2016 | 484 | 0.100 |
Why?
|
| Genes, fos | 2 | 2011 | 175 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 1994 | 4355 | 0.100 |
Why?
|
| Receptors, Prostaglandin E, EP1 Subtype | 2 | 2003 | 9 | 0.100 |
Why?
|
| Organ Specificity | 5 | 2006 | 1967 | 0.100 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2012 | 74 | 0.100 |
Why?
|
| Pyrogens | 1 | 1992 | 17 | 0.100 |
Why?
|
| Denervation | 2 | 2006 | 263 | 0.100 |
Why?
|
| Excitatory Amino Acid Agonists | 4 | 2011 | 144 | 0.100 |
Why?
|
| Cacao | 1 | 2013 | 98 | 0.100 |
Why?
|
| Diphtheria Toxin | 1 | 2013 | 252 | 0.100 |
Why?
|
| Tissue Fixation | 2 | 2008 | 241 | 0.100 |
Why?
|
| Aged | 28 | 2021 | 169179 | 0.100 |
Why?
|
| Electric Stimulation Therapy | 1 | 1998 | 627 | 0.100 |
Why?
|
| Axons | 5 | 2010 | 1674 | 0.100 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 127 | 0.100 |
Why?
|
| Obesity | 3 | 2022 | 12934 | 0.100 |
Why?
|
| Laughter | 1 | 2011 | 19 | 0.100 |
Why?
|
| Action Potentials | 6 | 2019 | 1834 | 0.100 |
Why?
|
| Neurons, Afferent | 3 | 1991 | 498 | 0.100 |
Why?
|
| Publications | 1 | 2014 | 194 | 0.100 |
Why?
|
| Environment | 2 | 2010 | 1122 | 0.100 |
Why?
|
| Time Perception | 1 | 2012 | 87 | 0.100 |
Why?
|
| Gait | 1 | 2017 | 816 | 0.100 |
Why?
|
| Microglia | 2 | 1998 | 1357 | 0.100 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1997 | 952 | 0.100 |
Why?
|
| Receptors, Corticotropin | 2 | 2003 | 24 | 0.100 |
Why?
|
| Glutamates | 1 | 1992 | 389 | 0.100 |
Why?
|
| Consensus | 2 | 2019 | 3122 | 0.090 |
Why?
|
| Dendrites | 5 | 2010 | 475 | 0.090 |
Why?
|
| Copper | 1 | 2014 | 369 | 0.090 |
Why?
|
| Water | 1 | 2017 | 1410 | 0.090 |
Why?
|
| Ghrelin | 1 | 2012 | 252 | 0.090 |
Why?
|
| Urinary Incontinence | 1 | 2015 | 489 | 0.090 |
Why?
|
| Muscle Weakness | 1 | 2014 | 413 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 3 | 2010 | 1086 | 0.090 |
Why?
|
| Telencephalon | 3 | 1986 | 142 | 0.090 |
Why?
|
| Cyclooxygenase 1 | 2 | 2016 | 97 | 0.090 |
Why?
|
| Sexual Behavior, Animal | 1 | 2011 | 120 | 0.090 |
Why?
|
| Gene Expression Regulation | 6 | 2011 | 11900 | 0.090 |
Why?
|
| Anesthetics, General | 1 | 2011 | 151 | 0.090 |
Why?
|
| Accidental Falls | 1 | 1998 | 1068 | 0.080 |
Why?
|
| Dynorphins | 3 | 2005 | 82 | 0.080 |
Why?
|
| Xanthines | 1 | 2009 | 120 | 0.080 |
Why?
|
| Injections, Intraventricular | 4 | 2003 | 225 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2016 | 1254 | 0.080 |
Why?
|
| Oncogene Proteins v-fos | 2 | 2009 | 16 | 0.080 |
Why?
|
| Starvation | 2 | 2008 | 141 | 0.080 |
Why?
|
| Schizophrenia | 4 | 2005 | 6937 | 0.080 |
Why?
|
| Delta Rhythm | 2 | 2019 | 81 | 0.080 |
Why?
|
| Adenoviridae | 1 | 2013 | 1084 | 0.080 |
Why?
|
| Tyrosine 3-Monooxygenase | 6 | 2010 | 370 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2003 | 10764 | 0.080 |
Why?
|
| Pro-Opiomelanocortin | 2 | 1999 | 140 | 0.080 |
Why?
|
| Blood-Brain Barrier | 2 | 2010 | 1025 | 0.080 |
Why?
|
| Epilepsy | 2 | 2021 | 3290 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2020 | 9639 | 0.080 |
Why?
|
| Isoflurane | 1 | 2011 | 384 | 0.080 |
Why?
|
| Reaction Time | 2 | 2013 | 2080 | 0.070 |
Why?
|
| DNA Primers | 3 | 1998 | 2820 | 0.070 |
Why?
|
| Protein Precursors | 3 | 2001 | 1134 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2022 | 36430 | 0.070 |
Why?
|
| Evolution, Molecular | 1 | 1996 | 1888 | 0.070 |
Why?
|
| ARNTL Transcription Factors | 1 | 2008 | 96 | 0.070 |
Why?
|
| Neuropeptide Y | 3 | 1999 | 192 | 0.070 |
Why?
|
| Arginine Vasopressin | 1 | 1987 | 125 | 0.070 |
Why?
|
| Frontal Lobe | 3 | 1990 | 1420 | 0.070 |
Why?
|
| Avoidance Learning | 1 | 2009 | 248 | 0.070 |
Why?
|
| Electrodes, Implanted | 2 | 2002 | 840 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 1999 | 8997 | 0.070 |
Why?
|
| Autoradiography | 8 | 1988 | 730 | 0.070 |
Why?
|
| Theta Rhythm | 2 | 2019 | 219 | 0.070 |
Why?
|
| Superior Colliculi | 3 | 2003 | 98 | 0.070 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 2006 | 8 | 0.070 |
Why?
|
| Facial Muscles | 1 | 1987 | 159 | 0.070 |
Why?
|
| Integrases | 4 | 2014 | 516 | 0.070 |
Why?
|
| Endorphins | 1 | 1986 | 74 | 0.070 |
Why?
|
| Sleep Paralysis | 1 | 2006 | 15 | 0.070 |
Why?
|
| Adult | 26 | 2018 | 221122 | 0.070 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 1986 | 25 | 0.070 |
Why?
|
| Peptides | 3 | 2003 | 4342 | 0.070 |
Why?
|
| Trigeminal Caudal Nucleus | 1 | 1985 | 18 | 0.070 |
Why?
|
| Syndrome | 1 | 2012 | 3268 | 0.060 |
Why?
|
| Cytokines | 2 | 1998 | 7390 | 0.060 |
Why?
|
| Food Deprivation | 1 | 2006 | 114 | 0.060 |
Why?
|
| Middle Aged | 23 | 2016 | 220774 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 5 | 1996 | 9180 | 0.060 |
Why?
|
| Hyperventilation | 1 | 2005 | 78 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 2006 | 462 | 0.060 |
Why?
|
| Memory, Short-Term | 1 | 2012 | 982 | 0.060 |
Why?
|
| Sincalide | 1 | 1985 | 15 | 0.060 |
Why?
|
| Hedgehog Proteins | 1 | 2010 | 768 | 0.060 |
Why?
|
| Substance P | 3 | 1997 | 335 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 3710 | 0.060 |
Why?
|
| Paraplegia | 1 | 1986 | 162 | 0.060 |
Why?
|
| Sweating | 1 | 1986 | 155 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 4 | 2012 | 6210 | 0.060 |
Why?
|
| Temperature | 3 | 2005 | 2229 | 0.060 |
Why?
|
| Systems Biology | 1 | 2008 | 481 | 0.060 |
Why?
|
| Unconsciousness | 1 | 2007 | 250 | 0.060 |
Why?
|
| Dura Mater | 2 | 2010 | 290 | 0.060 |
Why?
|
| Hypnotics and Sedatives | 2 | 2003 | 1178 | 0.060 |
Why?
|
| Reflex | 2 | 1986 | 376 | 0.060 |
Why?
|
| Violence | 1 | 2011 | 937 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3777 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 2 | 2003 | 412 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6231 | 0.060 |
Why?
|
| Extrapyramidal Tracts | 2 | 1987 | 18 | 0.060 |
Why?
|
| Dreams | 1 | 2005 | 146 | 0.060 |
Why?
|
| Organ Culture Techniques | 2 | 2006 | 794 | 0.060 |
Why?
|
| Enkephalin, Methionine | 2 | 1997 | 26 | 0.060 |
Why?
|
| Adenosine Deaminase | 2 | 2004 | 251 | 0.060 |
Why?
|
| Macaca mulatta | 3 | 2002 | 2332 | 0.060 |
Why?
|
| Benzothiazoles | 3 | 1994 | 247 | 0.060 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2004 | 77 | 0.060 |
Why?
|
| Death, Sudden | 1 | 2006 | 302 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 2 | 1995 | 317 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 4 | 1992 | 1704 | 0.060 |
Why?
|
| Tectum Mesencephali | 1 | 2003 | 18 | 0.060 |
Why?
|
| Turpentine | 1 | 2003 | 10 | 0.060 |
Why?
|
| Immunochemistry | 3 | 1991 | 119 | 0.060 |
Why?
|
| Genes, Immediate-Early | 1 | 2004 | 102 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 4432 | 0.060 |
Why?
|
| Irritants | 1 | 2003 | 43 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 2 | 1996 | 3836 | 0.050 |
Why?
|
| Geniculate Bodies | 2 | 2003 | 160 | 0.050 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2003 | 108 | 0.050 |
Why?
|
| Synaptic Membranes | 1 | 2003 | 89 | 0.050 |
Why?
|
| Neurotensin | 3 | 2000 | 60 | 0.050 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 539 | 0.050 |
Why?
|
| Syringes | 1 | 1983 | 57 | 0.050 |
Why?
|
| Blotting, Western | 4 | 1997 | 5034 | 0.050 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 1995 | 1723 | 0.050 |
Why?
|
| C-Reactive Protein | 2 | 2012 | 3824 | 0.050 |
Why?
|
| Muscle Proteins | 2 | 1985 | 1152 | 0.050 |
Why?
|
| Pressoreceptors | 2 | 1998 | 99 | 0.050 |
Why?
|
| Sensory Receptor Cells | 1 | 1987 | 513 | 0.050 |
Why?
|
| Species Specificity | 5 | 2001 | 2419 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2008 | 8526 | 0.050 |
Why?
|
| International Cooperation | 1 | 2009 | 1428 | 0.050 |
Why?
|
| Weight Gain | 1 | 2012 | 2346 | 0.050 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2003 | 177 | 0.050 |
Why?
|
| Receptors, Glucagon | 1 | 2002 | 90 | 0.050 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2003 | 91 | 0.050 |
Why?
|
| Angina Pectoris | 1 | 2006 | 959 | 0.050 |
Why?
|
| Biogenic Monoamines | 1 | 2002 | 50 | 0.050 |
Why?
|
| Macrophages | 1 | 1997 | 5768 | 0.050 |
Why?
|
| Venoms | 1 | 2002 | 95 | 0.050 |
Why?
|
| Aotidae | 1 | 2002 | 59 | 0.050 |
Why?
|
| Confidentiality | 1 | 2006 | 609 | 0.050 |
Why?
|
| Receptors, Cholecystokinin | 1 | 2001 | 18 | 0.050 |
Why?
|
| Lectins | 4 | 1991 | 491 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 14665 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 4286 | 0.050 |
Why?
|
| Nociceptors | 2 | 2006 | 461 | 0.050 |
Why?
|
| Necrosis | 1 | 2006 | 1605 | 0.050 |
Why?
|
| Ion Channels | 1 | 2006 | 1040 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2003 | 680 | 0.050 |
Why?
|
| Research Design | 2 | 2009 | 6178 | 0.050 |
Why?
|
| Thermosensing | 1 | 2001 | 55 | 0.050 |
Why?
|
| Receptors, Somatostatin | 2 | 1992 | 136 | 0.050 |
Why?
|
| Cost Savings | 1 | 2007 | 913 | 0.050 |
Why?
|
| Methyl Ethers | 1 | 2003 | 196 | 0.050 |
Why?
|
| Photoperiod | 1 | 2002 | 139 | 0.050 |
Why?
|
| Synaptic Vesicles | 1 | 2003 | 190 | 0.050 |
Why?
|
| Lipids | 1 | 2012 | 3341 | 0.050 |
Why?
|
| Oculomotor Nerve | 2 | 1978 | 72 | 0.050 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2003 | 321 | 0.050 |
Why?
|
| Biology | 1 | 2023 | 289 | 0.050 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2001 | 39 | 0.050 |
Why?
|
| Dopamine Agonists | 1 | 2003 | 352 | 0.050 |
Why?
|
| Troponin T | 1 | 2006 | 779 | 0.050 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2000 | 48 | 0.050 |
Why?
|
| Stimulation, Chemical | 2 | 1998 | 306 | 0.050 |
Why?
|
| Massachusetts | 1 | 2014 | 8837 | 0.050 |
Why?
|
| Genes, Reporter | 3 | 2003 | 1528 | 0.050 |
Why?
|
| Parietal Lobe | 1 | 2006 | 851 | 0.050 |
Why?
|
| Hypothalamus, Middle | 2 | 1979 | 15 | 0.050 |
Why?
|
| Anorexia | 1 | 2001 | 154 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2016 | 22124 | 0.050 |
Why?
|
| Biological Evolution | 1 | 2006 | 1073 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2006 | 979 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 26108 | 0.040 |
Why?
|
| Tuber Cinereum | 1 | 2000 | 1 | 0.040 |
Why?
|
| Receptors, Leptin | 2 | 2000 | 350 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2018 | 41440 | 0.040 |
Why?
|
| Rodentia | 1 | 2002 | 262 | 0.040 |
Why?
|
| Consciousness | 2 | 2005 | 601 | 0.040 |
Why?
|
| GABA Antagonists | 3 | 2007 | 120 | 0.040 |
Why?
|
| Amidines | 2 | 1991 | 29 | 0.040 |
Why?
|
| Receptors, Melanocortin | 1 | 1999 | 23 | 0.040 |
Why?
|
| Hyperthermia, Induced | 1 | 2003 | 417 | 0.040 |
Why?
|
| Transcription, Genetic | 5 | 2004 | 7597 | 0.040 |
Why?
|
| Satiety Response | 1 | 1999 | 47 | 0.040 |
Why?
|
| Somatostatin | 2 | 1993 | 447 | 0.040 |
Why?
|
| Lumbosacral Plexus | 1 | 1999 | 51 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 7045 | 0.040 |
Why?
|
| District of Columbia | 1 | 2019 | 159 | 0.040 |
Why?
|
| Migraine Disorders | 2 | 2010 | 1700 | 0.040 |
Why?
|
| Neurosecretory Systems | 1 | 2000 | 223 | 0.040 |
Why?
|
| Lymphoma, B-Cell | 1 | 2005 | 940 | 0.040 |
Why?
|
| Olfactory Pathways | 1 | 2000 | 132 | 0.040 |
Why?
|
| Medical Illustration | 1 | 1999 | 135 | 0.040 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1980 | 166 | 0.040 |
Why?
|
| Smoking | 1 | 1995 | 9051 | 0.040 |
Why?
|
| RNA Probes | 1 | 1998 | 111 | 0.040 |
Why?
|
| Movement | 1 | 2005 | 1478 | 0.040 |
Why?
|
| Lysine | 3 | 1997 | 991 | 0.040 |
Why?
|
| Dexmedetomidine | 1 | 2003 | 319 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 4 | 2008 | 2648 | 0.040 |
Why?
|
| Electrodiagnosis | 1 | 1999 | 148 | 0.040 |
Why?
|
| Information Services | 1 | 1999 | 237 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2012 | 6389 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2024 | 2509 | 0.040 |
Why?
|
| Recombination, Genetic | 2 | 2003 | 1526 | 0.040 |
Why?
|
| Electrophysiology | 2 | 2003 | 1262 | 0.040 |
Why?
|
| Sex Factors | 1 | 2011 | 10551 | 0.040 |
Why?
|
| Heart Rate | 3 | 2002 | 4197 | 0.040 |
Why?
|
| Transcription Factors | 4 | 2008 | 12122 | 0.040 |
Why?
|
| Neural Conduction | 1 | 1999 | 441 | 0.040 |
Why?
|
| Ketorolac | 1 | 1998 | 94 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2017 | 174 | 0.040 |
Why?
|
| Carbocyanines | 1 | 1997 | 175 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2678 | 0.040 |
Why?
|
| Receptors, Dopamine D1 | 2 | 2016 | 293 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 20092 | 0.030 |
Why?
|
| Confusion | 1 | 1999 | 278 | 0.030 |
Why?
|
| Cerebellar Neoplasms | 1 | 1982 | 586 | 0.030 |
Why?
|
| Autonomic Pathways | 1 | 1996 | 31 | 0.030 |
Why?
|
| Social Behavior | 1 | 2003 | 1134 | 0.030 |
Why?
|
| Goats | 1 | 1996 | 167 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 3448 | 0.030 |
Why?
|
| Social Responsibility | 1 | 1999 | 386 | 0.030 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1998 | 266 | 0.030 |
Why?
|
| Excitatory Amino Acids | 1 | 1995 | 17 | 0.030 |
Why?
|
| Immune Sera | 2 | 1987 | 613 | 0.030 |
Why?
|
| Base Sequence | 3 | 1996 | 12449 | 0.030 |
Why?
|
| Adenosine A1 Receptor Antagonists | 2 | 2006 | 27 | 0.030 |
Why?
|
| History, 17th Century | 1 | 1995 | 107 | 0.030 |
Why?
|
| Tissue Distribution | 5 | 2006 | 2265 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2008 | 5794 | 0.030 |
Why?
|
| Perception | 1 | 2002 | 1197 | 0.030 |
Why?
|
| Benzidines | 2 | 1985 | 6 | 0.030 |
Why?
|
| Software | 2 | 2001 | 4439 | 0.030 |
Why?
|
| Membrane Proteins | 3 | 2016 | 7852 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2001 | 1985 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1996 | 2749 | 0.030 |
Why?
|
| Age Factors | 1 | 2011 | 18401 | 0.030 |
Why?
|
| Nucleus Accumbens | 1 | 1997 | 366 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2006 | 2656 | 0.030 |
Why?
|
| Neurons, Efferent | 3 | 1979 | 81 | 0.030 |
Why?
|
| Visual Pathways | 1 | 1999 | 551 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2005 | 2977 | 0.030 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2013 | 17 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 1996 | 17640 | 0.030 |
Why?
|
| Diprenorphine | 1 | 1993 | 13 | 0.030 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2013 | 25 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1996 | 412 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1999 | 1833 | 0.030 |
Why?
|
| Autopsy | 1 | 1998 | 1006 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 2 | 1985 | 325 | 0.030 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2014 | 108 | 0.030 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2013 | 37 | 0.030 |
Why?
|
| Chronic Disease | 2 | 1999 | 9319 | 0.030 |
Why?
|
| Melatonin | 2 | 2013 | 669 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2011 | 12949 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 1998 | 592 | 0.030 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2013 | 89 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 371 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 1999 | 12972 | 0.030 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1997 | 389 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2003 | 1976 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2000 | 874 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 1996 | 4175 | 0.030 |
Why?
|
| Gyrus Cinguli | 4 | 1997 | 1115 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2009 | 7954 | 0.030 |
Why?
|
| Methyltyrosines | 1 | 1973 | 7 | 0.030 |
Why?
|
| NADPH Dehydrogenase | 1 | 1993 | 44 | 0.030 |
Why?
|
| Clonazepam | 1 | 2013 | 135 | 0.030 |
Why?
|
| Swine | 2 | 1995 | 5915 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 1993 | 225 | 0.030 |
Why?
|
| Sacrum | 1 | 2015 | 276 | 0.030 |
Why?
|
| Multigene Family | 1 | 1996 | 1077 | 0.030 |
Why?
|
| GABA Modulators | 1 | 2013 | 109 | 0.030 |
Why?
|
| Saimiri | 3 | 1979 | 334 | 0.030 |
Why?
|
| Lambert-Eaton Myasthenic Syndrome | 1 | 1992 | 8 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2000 | 1198 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1993 | 815 | 0.030 |
Why?
|
| Cell Line | 2 | 2016 | 15599 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2003 | 2007 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2006 | 6382 | 0.030 |
Why?
|
| Macaca | 2 | 2009 | 411 | 0.030 |
Why?
|
| GABA-A Receptor Agonists | 2 | 2003 | 86 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 4850 | 0.030 |
Why?
|
| Receptors, N-Acetylglucosamine | 1 | 2012 | 11 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2006 | 3048 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 1994 | 344 | 0.030 |
Why?
|
| Rhombencephalon | 1 | 1992 | 81 | 0.030 |
Why?
|
| Vasopressins | 1 | 1993 | 351 | 0.030 |
Why?
|
| Cerebellar Cortex | 1 | 1993 | 107 | 0.030 |
Why?
|
| Plant Lectins | 1 | 2012 | 103 | 0.020 |
Why?
|
| Olfactory Bulb | 2 | 1984 | 198 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 36202 | 0.020 |
Why?
|
| Pyramidal Cells | 1 | 1994 | 369 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 6525 | 0.020 |
Why?
|
| Rats, Inbred F344 | 2 | 2003 | 826 | 0.020 |
Why?
|
| Microelectrodes | 1 | 1992 | 306 | 0.020 |
Why?
|
| Injections | 1 | 1994 | 830 | 0.020 |
Why?
|
| Ganglia | 1 | 1991 | 87 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1996 | 2217 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 1994 | 563 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1998 | 1272 | 0.020 |
Why?
|
| Fornix, Brain | 2 | 2001 | 71 | 0.020 |
Why?
|
| Adipocytes | 1 | 1998 | 1192 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 1751 | 0.020 |
Why?
|
| Shock | 1 | 1993 | 314 | 0.020 |
Why?
|
| Discrimination Learning | 1 | 1973 | 278 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2004 | 178 | 0.020 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1992 | 155 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 14025 | 0.020 |
Why?
|
| Headache | 1 | 1999 | 1256 | 0.020 |
Why?
|
| Macaca fascicularis | 2 | 1987 | 903 | 0.020 |
Why?
|
| Pigmentation | 1 | 1991 | 144 | 0.020 |
Why?
|
| Cattle | 1 | 1996 | 3849 | 0.020 |
Why?
|
| Thoracic Vertebrae | 1 | 2015 | 596 | 0.020 |
Why?
|
| Exons | 1 | 1996 | 2392 | 0.020 |
Why?
|
| Deep Brain Stimulation | 1 | 2019 | 832 | 0.020 |
Why?
|
| Cerebellar Diseases | 1 | 1992 | 220 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1996 | 2048 | 0.020 |
Why?
|
| Glucose | 1 | 2022 | 4345 | 0.020 |
Why?
|
| Walking | 1 | 2017 | 1200 | 0.020 |
Why?
|
| Gold | 1 | 1993 | 478 | 0.020 |
Why?
|
| beta-Galactosidase | 2 | 2003 | 574 | 0.020 |
Why?
|
| Phenylethanolamine N-Methyltransferase | 2 | 1987 | 18 | 0.020 |
Why?
|
| Appetitive Behavior | 1 | 2009 | 39 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2012 | 559 | 0.020 |
Why?
|
| Electroshock | 1 | 2009 | 121 | 0.020 |
Why?
|
| Renal Artery | 1 | 1990 | 351 | 0.020 |
Why?
|
| Biological Transport | 2 | 2000 | 2090 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1993 | 796 | 0.020 |
Why?
|
| Posture | 2 | 1999 | 956 | 0.020 |
Why?
|
| Cell Shape | 1 | 2010 | 371 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 1996 | 13446 | 0.020 |
Why?
|
| Phenotype | 3 | 2012 | 16603 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 2009 | 181 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 1998 | 1906 | 0.020 |
Why?
|
| Vasomotor System | 2 | 1987 | 207 | 0.020 |
Why?
|
| Cardiac Output | 1 | 1990 | 837 | 0.020 |
Why?
|
| Tetanus Toxin | 1 | 1987 | 46 | 0.020 |
Why?
|
| Weight Loss | 1 | 1999 | 2683 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 1994 | 1301 | 0.020 |
Why?
|
| Bicuculline | 1 | 2007 | 96 | 0.020 |
Why?
|
| Maze Learning | 1 | 2009 | 482 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 6086 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1987 | 293 | 0.020 |
Why?
|
| Comorbidity | 1 | 2021 | 10498 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 9605 | 0.020 |
Why?
|
| Phenoxybenzamine | 1 | 1986 | 53 | 0.020 |
Why?
|
| Adenosine A1 Receptor Agonists | 1 | 2006 | 13 | 0.020 |
Why?
|
| Receptors, Ghrelin | 1 | 2006 | 20 | 0.020 |
Why?
|
| Ganglia, Parasympathetic | 1 | 2006 | 18 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2007 | 202 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 2009 | 368 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1982 | 3613 | 0.020 |
Why?
|
| Blindness | 1 | 2010 | 584 | 0.020 |
Why?
|
| Phenothiazines | 1 | 1985 | 61 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 1879 | 0.020 |
Why?
|
| Muscle Tonus | 1 | 2005 | 82 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2005 | 119 | 0.020 |
Why?
|
| Chromogenic Compounds | 1 | 1985 | 31 | 0.020 |
Why?
|
| Child | 3 | 2021 | 80156 | 0.020 |
Why?
|
| Leucine | 2 | 1976 | 548 | 0.020 |
Why?
|
| Young Adult | 3 | 2018 | 59196 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 11454 | 0.020 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2006 | 130 | 0.020 |
Why?
|
| Atrial Function | 1 | 1985 | 99 | 0.020 |
Why?
|
| Proline | 2 | 1976 | 457 | 0.020 |
Why?
|
| Peroxidases | 1 | 1985 | 134 | 0.020 |
Why?
|
| Theophylline | 1 | 2005 | 131 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 696 | 0.010 |
Why?
|
| Heart Atria | 1 | 1990 | 1346 | 0.010 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2005 | 75 | 0.010 |
Why?
|
| Cell Death | 1 | 2010 | 1674 | 0.010 |
Why?
|
| Tristetraprolin | 1 | 2004 | 38 | 0.010 |
Why?
|
| Anesthesia, General | 1 | 2011 | 1174 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 2498 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 9030 | 0.010 |
Why?
|
| Supraoptic Nucleus | 2 | 1985 | 28 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1998 | 12329 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1986 | 617 | 0.010 |
Why?
|
| Lithium Chloride | 1 | 2004 | 82 | 0.010 |
Why?
|
| Cues | 1 | 2009 | 875 | 0.010 |
Why?
|
| Epinephrine | 2 | 1985 | 792 | 0.010 |
Why?
|
| Body Fluids | 1 | 1985 | 319 | 0.010 |
Why?
|
| Septal Nuclei | 1 | 1984 | 85 | 0.010 |
Why?
|
| Microchemistry | 1 | 1983 | 54 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 1986 | 555 | 0.010 |
Why?
|
| Potassium Channels | 1 | 2006 | 537 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 623 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1993 | 4167 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 1436 | 0.010 |
Why?
|
| Facial Paralysis | 1 | 1987 | 345 | 0.010 |
Why?
|
| Monocytes | 1 | 2012 | 2573 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 2724 | 0.010 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2003 | 69 | 0.010 |
Why?
|
| Protein Biosynthesis | 2 | 2001 | 2114 | 0.010 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2002 | 60 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2003 | 174 | 0.010 |
Why?
|
| Neurotoxins | 1 | 2003 | 240 | 0.010 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2003 | 129 | 0.010 |
Why?
|
| Adolescent | 4 | 2012 | 88305 | 0.010 |
Why?
|
| Tritium | 1 | 1982 | 707 | 0.010 |
Why?
|
| Septum Pellucidum | 1 | 1982 | 54 | 0.010 |
Why?
|
| GABA Agonists | 1 | 2002 | 105 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2011 | 42251 | 0.010 |
Why?
|
| Heart Failure | 1 | 2006 | 11672 | 0.010 |
Why?
|
| Midline Thalamic Nuclei | 1 | 2001 | 14 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 579 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2012 | 2727 | 0.010 |
Why?
|
| Autoantibodies | 2 | 2005 | 2123 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2005 | 591 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1998 | 10203 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 449 | 0.010 |
Why?
|
| Pyridazines | 1 | 2003 | 202 | 0.010 |
Why?
|
| Cell Survival | 1 | 1991 | 5792 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 2001 | 80 | 0.010 |
Why?
|
| Phenethylamines | 1 | 2001 | 95 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2001 | 621 | 0.010 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2000 | 109 | 0.010 |
Why?
|
| Models, Animal | 1 | 2007 | 2112 | 0.010 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2001 | 128 | 0.010 |
Why?
|
| Cerebellar Ataxia | 1 | 1982 | 150 | 0.010 |
Why?
|
| Enkephalins | 1 | 2000 | 139 | 0.010 |
Why?
|
| Cytarabine | 1 | 1982 | 697 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 2002 | 551 | 0.010 |
Why?
|
| Cervical Vertebrae | 1 | 2006 | 981 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 1999 | 135 | 0.010 |
Why?
|
| Communicable Diseases | 1 | 1987 | 880 | 0.010 |
Why?
|
| Medial Forebrain Bundle | 1 | 1979 | 43 | 0.010 |
Why?
|
| Methamphetamine | 1 | 2001 | 165 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 3592 | 0.010 |
Why?
|
| Dog Diseases | 1 | 1999 | 141 | 0.010 |
Why?
|
| Cerebral Aqueduct | 1 | 1978 | 40 | 0.010 |
Why?
|
| Agouti-Related Protein | 1 | 1998 | 93 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1990 | 3816 | 0.010 |
Why?
|
| Postural Balance | 1 | 2003 | 621 | 0.010 |
Why?
|
| Urination | 1 | 1979 | 203 | 0.010 |
Why?
|
| Antihypertensive Agents | 2 | 2001 | 2023 | 0.010 |
Why?
|
| Genotype | 1 | 2012 | 12982 | 0.010 |
Why?
|
| Lac Operon | 1 | 1997 | 237 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 7999 | 0.010 |
Why?
|
| Trigeminal Nerve | 1 | 1978 | 248 | 0.010 |
Why?
|
| Imidazoles | 1 | 2003 | 1179 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 13500 | 0.010 |
Why?
|
| Meninges | 1 | 1998 | 198 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 6374 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 1803 | 0.010 |
Why?
|
| Visual Cortex | 1 | 1984 | 1107 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2000 | 743 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 1978 | 526 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 1999 | 761 | 0.010 |
Why?
|
| Methotrexate | 1 | 1982 | 1720 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2003 | 1875 | 0.010 |
Why?
|
| Dogs | 1 | 1999 | 3839 | 0.010 |
Why?
|
| Bethanechol Compounds | 1 | 1993 | 10 | 0.010 |
Why?
|
| Enkephalin, Leucine | 1 | 1993 | 16 | 0.010 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 1993 | 20 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 5202 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 15719 | 0.010 |
Why?
|
| Age of Onset | 1 | 1999 | 3303 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1992 | 780 | 0.010 |
Why?
|
| Schizophrenic Psychology | 1 | 1999 | 1647 | 0.010 |
Why?
|
| Pyrrolidines | 1 | 1993 | 338 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1982 | 6309 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 9468 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1998 | 1650 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 1998 | 64645 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 21336 | 0.010 |
Why?
|
| Naloxone | 1 | 1993 | 370 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 1545 | 0.010 |
Why?
|
| Appetite | 1 | 1973 | 247 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2000 | 3701 | 0.010 |
Why?
|
| Gastrointestinal Motility | 1 | 1991 | 234 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1999 | 6019 | 0.000 |
Why?
|
| Narcotic Antagonists | 1 | 1993 | 585 | 0.000 |
Why?
|
| Cyclic AMP | 1 | 1992 | 1462 | 0.000 |
Why?
|
| GTP-Binding Proteins | 1 | 1992 | 950 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 6332 | 0.000 |
Why?
|
| Rats, Inbred Lew | 1 | 1988 | 1158 | 0.000 |
Why?
|
| Risk Factors | 1 | 2013 | 74152 | 0.000 |
Why?
|
| Colorectal Neoplasms | 1 | 2005 | 6901 | 0.000 |
Why?
|
| Natriuresis | 1 | 1985 | 105 | 0.000 |
Why?
|
| DNA | 2 | 1992 | 7216 | 0.000 |
Why?
|
| Occipital Lobe | 1 | 1987 | 374 | 0.000 |
Why?
|
| Thiocyanates | 1 | 1985 | 70 | 0.000 |
Why?
|
| Substantia Nigra | 1 | 1987 | 350 | 0.000 |
Why?
|
| Fluoresceins | 1 | 1985 | 235 | 0.000 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1985 | 223 | 0.000 |
Why?
|
| Renal Circulation | 1 | 1985 | 291 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1985 | 866 | 0.000 |
Why?
|
| Drug Stability | 1 | 1984 | 291 | 0.000 |
Why?
|
| Body Water | 1 | 1985 | 340 | 0.000 |
Why?
|
| Cyclic GMP | 1 | 1985 | 395 | 0.000 |
Why?
|
| Vestibular Nuclei | 1 | 1983 | 22 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2012 | 80575 | 0.000 |
Why?
|
| Neoplasms | 1 | 1992 | 22158 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1985 | 563 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1982 | 9275 | 0.000 |
Why?
|
| Renin | 1 | 1985 | 639 | 0.000 |
Why?
|
| Acute Disease | 1 | 1993 | 7238 | 0.000 |
Why?
|
| Cranial Nerves | 1 | 1983 | 98 | 0.000 |
Why?
|
| Sodium | 1 | 1985 | 1588 | 0.000 |
Why?
|
| Mental Disorders | 1 | 1999 | 6839 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1982 | 20555 | 0.000 |
Why?
|
| Terminology as Topic | 1 | 1985 | 1535 | 0.000 |
Why?
|
| Kidney | 1 | 1985 | 7049 | 0.000 |
Why?
|